Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.120
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.130
+0.010 (0.89%)
Pre-market: Mar 10, 2026, 8:00 AM EDT

Bionano Genomics Revenue

Bionano Genomics had revenue of $7.37M in the quarter ending September 30, 2025, with 21.31% growth. This brings the company's revenue in the last twelve months to $28.72M, down -13.84% year-over-year. In the year 2024, Bionano Genomics had annual revenue of $30.78M, down -14.79%.

Revenue (ttm)
$28.72M
Revenue Growth
-13.84%
P/S Ratio
0.40
Revenue / Employee
$287,200
Employees
100
Market Cap
11.40M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202430.78M-5.34M-14.79%
Dec 31, 202336.12M8.31M29.90%
Dec 31, 202227.80M9.82M54.62%
Dec 31, 202117.98M9.48M111.47%
Dec 31, 20208.50M-1.63M-16.06%
Dec 31, 201910.13M-1.87M-15.59%
Dec 31, 201812.00M2.50M26.26%
Dec 31, 20179.51M2.71M39.93%
Dec 31, 20166.79M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition